Holocene Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-842,563
| Closed | -$21.3M | – | 898 |
|
|
2023
Q2 | $21.3M | Sell |
842,563
-93,852
| -10% | -$2.38M | 0.09% | 201 |
|
|
2023
Q1 | $30.2M | Sell |
936,415
-370,245
| -28% | -$11.9M | 0.15% | 167 |
|
|
2022
Q4 | $24.1M | Buy |
1,306,660
+240,698
| +23% | +$4.44M | 0.15% | 161 |
|
|
2022
Q3 | $28.8M | Buy |
+1,065,962
| New | +$28.8M | 0.18% | 150 |
|